Chardan Capital Markets Downgrades CervoMed (CRVO) to Neutral
Tweet Send to a Friend
Chardan Capital Markets analyst Danill Gataulin downgraded CervoMed (NASDAQ: CRVO) from Buy to Neutral.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
